NATALEE

Name No. For Patients with Purpose
NATALEE 18-41 (CLEE011O12301C)

Early Breast Cancer

The purpose of this study is to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant treatment in patients with HR+/HER2- Early Breast Cancer.


KEYNOTE-756

Name No. For Patients with Purpose
KEYNOTE-756 18-05 (MK-3475-756)

Newly Diagnosed Breast Cancer

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with pre-surgery chemotherapy and post-surgery endocrine therapy in the treatment of adults who have high-risk early-stage ER+/HER2- breast cancer.


ALEXANDRA/IMpassion030

Name No. For Patients with Purpose
ALEXANDRA/IMpassion030 17-15 (WO39391 / BIG 16-05)

Early stage breast cancer

This study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant atezolizumab.


Proteomics / Molecular Breast

Name No. For Patients with Purpose
Proteomics / Molecular Breast 09-07

Breast cancer

The purpose of this trial is to examine the function of different genes and proteins, previously identified to be of interest, and identify new ones, as well as the means by which they interact and differ between cancer cells.